A Study of Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs
Clinical trial NCT00810277 · COMPLETED
Trial details
- NCT number
- NCT00810277
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-30
- Primary completion
- 2010-05-26
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.